These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 6093961
41. [A microelectrode study of the antagonism of d-tubocurarine induced neuromuscular blockade by edrophonium and neostigmine]. Narimatsu E. Masui; 1993 Jan; 42(1):25-36. PubMed ID: 8433489 [Abstract] [Full Text] [Related]
42. Bradycardia during antagonism of pancuronium-induced neuromuscular block. Heinonen J, Takkunen O. Br J Anaesth; 1977 Nov; 49(11):1109-15. PubMed ID: 588391 [Abstract] [Full Text] [Related]
43. Antagonism of alcuronium with edrophonium or neostigmine. Harper NJ, Bradshaw EG, Healy TE. Br J Anaesth; 1984 Oct; 56(10):1089-94. PubMed ID: 6089857 [Abstract] [Full Text] [Related]
44. Atracurium after an anticholinesterase. Does prior reversal with edrophonium or neostigmine influence the response to atracurium? Shorten GD, Ali HA. Anaesthesia; 1993 Jun; 48(6):524-6. PubMed ID: 8322995 [Abstract] [Full Text] [Related]
50. Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium. Goldhill DR, Embree PB, Ali HH, Savarese JJ. Anaesthesia; 1988 Jun; 43(6):443-6. PubMed ID: 3407868 [Abstract] [Full Text] [Related]
51. The effect of calcium, neostigmine and 4-aminopyridine upon respiratory arrest and depression of cardiovascular functions after aminoglycosidic antibiotics. Sobek V. Arzneimittelforschung; 1982 Jun; 32(3):222-4. PubMed ID: 7200780 [Abstract] [Full Text] [Related]
52. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade. Abdulatif M, Naguib M. Can J Anaesth; 1991 Mar; 38(2):159-63. PubMed ID: 1850665 [Abstract] [Full Text] [Related]
53. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade]. Bartunek A, Gilly H, Huemer G, Yildiz S, Schramm W, Lackner FX, Foldes FF. Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184 [Abstract] [Full Text] [Related]
54. Interaction of halothane with non-depolarizing neuromuscular blocking drugs in man. Hughes R, Payne JP. Br J Clin Pharmacol; 1979 May; 7(5):485-90. PubMed ID: 157769 [Abstract] [Full Text] [Related]
55. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children. Bevan JC, Tousignant C, Stephenson C, Blackman L, Reimer E, Smith MF, Bevan DR. Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666 [Abstract] [Full Text] [Related]
56. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium. Rupp SM, McChristian JW, Miller RD, Taboada JA, Cronnelly R. Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839 [Abstract] [Full Text] [Related]
57. Interaction of 2,4-diaminopyridine with cholinesterase inhibitors. Biessels PT, Houwertjes MC, Agoston S, Horn AS. Arch Int Pharmacodyn Ther; 1988 Jun; 293():228-35. PubMed ID: 3421780 [Abstract] [Full Text] [Related]